Weiwei Xue

According to our database, Weiwei Xue authored at least 22 papers between 2012 and 2024.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2024

Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives.

Gao Tu, Tingting Fu, Guoxun Zheng, Binbin Xu, Rongpei Gou, Ding Luo, Panpan Wang, Weiwei Xue

J. Chem. Inf. Model., March, 2024

Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine.

Xiaojie Jin, Min Zhang, Beibei Fu, Mi Li, Jingyi Yang, Zhiming Zhang, Chenghao Li, Huijuan Zhang, Haibo Wu, Weiwei Xue, Yongqi Liu

J. Chem. Inf. Model., February, 2024

MoDAFold: a strategy for predicting the structure of missense mutant protein based on AlphaFold2 and molecular dynamics.

Lingyan Zheng, Shuiyang Shi, Xiuna Sun, Mingkun Lu, Yang Liao, Sisi Zhu, Hongning Zhang, Ziqi Pan, Pan Fang, Zhenyu Zeng, Honglin Li, Zhaorong Li, Weiwei Xue, Feng Zhu

Briefings Bioinform., January, 2024

2023

Mapping synthetic binding proteins epitopes on diverse protein targets by protein structure prediction and protein-protein docking.

Arzu Mijit, Xiaona Wang, Yanlin Li, Hangwei Xu, Yingjun Chen, Weiwei Xue

Comput. Biol. Medicine, September, 2023

Structure-Based Discovery of a Novel Allosteric Inhibitor against Human Dopamine Transporter.

Shengzhe Deng, Haiwei Zhang, Rongpei Gou, Ding Luo, Zerong Liu, Feng Zhu, Weiwei Xue

J. Chem. Inf. Model., July, 2023

Unbiased molecular dynamics simulation of a first-in-class small molecule inhibitor binds to oncostatin M.

Qingqing Du, Gao Tu, Yan Qian, Jingyi Yang, Xiaojun Yao, Weiwei Xue

Comput. Biol. Medicine, March, 2023

2022

SYNBIP: synthetic binding proteins for research, diagnosis and therapy.

Xiaona Wang, Fengcheng Li, Wenqi Qiu, Binbin Xu, Yanlin Li, Xichen Lian, Hongyan Yu, Zhao Zhang, Jianxin Wang, Zhaorong Li, Weiwei Xue, Feng Zhu

Nucleic Acids Res., 2022

Character embedding-based Bi-LSTM for Zircon similarity calculation with clustering.

Xiangben Hu, Zhichen Hu, Jielin Jiang, Weiwei Xue, Xiumian Hu, Xiaolong Xu

Earth Sci. Informatics, 2022

2021

GIMICA: host genetic and immune factors shaping human microbiota.

Jing Tang, Xianglu Wu, Minjie Mou, Chuan Wang, Lidan Wang, Fengcheng Li, Maiyuan Guo, Jiayi Yin, Wenqin Xie, Xiaona Wang, Yingxiong Wang, Yubin Ding, Weiwei Xue, Feng Zhu

Nucleic Acids Res., 2021

Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro.

Jingyi Yang, Xiaoyuan Lin, Na Xing, Zhao Zhang, Haiwei Zhang, Haibo Wu, Weiwei Xue

J. Chem. Inf. Model., 2021

2020

Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data.

Qingxia Yang, Bo Li, Jing Tang, Xuejiao Cui, Yunxia Wang, Xiaofeng Li, Jie Hu, Yuzong Chen, Weiwei Xue, Yan Lou, Yunqing Qiu, Feng Zhu

Briefings Bioinform., 2020

A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

Qingxia Yang, Jiajun Hong, Yi Li, Weiwei Xue, Song Li, Hui Yang, Feng Zhu

Briefings Bioinform., 2020

A critical assessment of the feature selection methods used for biomarker discovery in current metaproteomics studies.

Jing Tang, Yunxia Wang, Jianbo Fu, Ying Zhou, Yongchao Luo, Ying Zhang, Bo Li, Qingxia Yang, Weiwei Xue, Yan Lou, Yunqing Qiu, Feng Zhu

Briefings Bioinform., 2020

ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies.

Jing Tang, Jianbo Fu, Yunxia Wang, Bo Li, Yinghong Li, Qingxia Yang, Xuejiao Cui, Jiajun Hong, Xiaofeng Li, Yuzong Chen, Weiwei Xue, Feng Zhu

Briefings Bioinform., 2020

Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.

Ying Hong Li, Xiao Xu Li, Jiajun Hong, Yunxia Wang, Jianbo Fu, Hong Yang, Chun Yan Yu, Feng Cheng Li, Jie Hu, Weiwei Xue, Yu Yang Jiang, Yu Zong Chen, Feng Zhu

Briefings Bioinform., 2020

Protein functional annotation of simultaneously improved stability, accuracy and false discovery rate achieved by a sequence-based deep learning.

Jiajun Hong, Yongchao Luo, Yang Zhang, Junbiao Ying, Weiwei Xue, Tian Xie, Lin Tao, Feng Zhu

Briefings Bioinform., 2020

Convolutional neural network-based annotation of bacterial type IV secretion system effectors with enhanced accuracy and reduced false discovery.

Jiajun Hong, Yongchao Luo, Minjie Mou, Jianbo Fu, Yang Zhang, Weiwei Xue, Tian Xie, Lin Tao, Yan Lou, Feng Zhu

Briefings Bioinform., 2020

Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data.

Zhijie Han, Weiwei Xue, Lin Tao, Yan Lou, Yunqing Qiu, Feng Zhu

Briefings Bioinform., 2020

2017

NOREVA: normalization and evaluation of MS-based metabolomics data.

Bo Li, Jing Tang, Qingxia Yang, Shuang Li, Xuejiao Cui, Yinghong Li, Yuzong Chen, Weiwei Xue, Xiaofeng Li, Feng Zhu

Nucleic Acids Res., 2017

2014

Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis.

Weiwei Xue, Yihe Ban, Huanxiang Liu, Xiaojun Yao

J. Chem. Inf. Model., 2014

2013

Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis.

Weiwei Xue, Xiaojie Jin, Lulu Ning, Meixia Wang, Huanxiang Liu, Xiaojun Yao

J. Chem. Inf. Model., 2013

2012

Molecular mechanism of HIV-1 integrase-vDNA interactions and strand transfer inhibitor action: A molecular modeling perspective.

Weiwei Xue, Huanxiang Liu, Xiaojun Yao

J. Comput. Chem., 2012